Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery ...
Researchers led by the Institut Pasteur, Université Paris, have developed a vaccine that elicits anti-Immunoglobulin E ...
This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...
Presentations showcase the power of omnimodal profiling to identify predictive immune signatures, comprehensively profile the tumor microenvironment and reveal novel therapeutic targets for optimized ...
OpenBench, Inc., a biotechnology company pioneering success-driven molecular discovery partnerships, and Brii Biosciences Limited, a biotechnology company developing therapies to improve patient ...
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...
The data demonstrated that finite-duration 24-week AHB-137 monotherapy achieved a 30% functional cure rate at Week 72 (EOF) in patients with baseline HBsAg 100–1,000 IU/mL. This finding strengthens ...
The CDC Advisory Committee on Immunization Practices met last week, eliminating the universal recommendation for the birth ...
Molecular Biology is the field of biology that studies the composition, structure and interactions of cellular molecules such as nucleic acids and proteins that carry out the biological processes ...
Computational biology and bioinformatics is an interdisciplinary field that develops and applies computational methods to analyse large collections of biological data, such as genetic sequences, cell ...